How to Select a CMO in Biomanufacturing
Experts often regard biomanufacturing efficiency as the most important part of global bioprocessing. But efficiency can be almost impossible as companies juggle hundreds of priorities across dozens of areas in the pipeline. Best practice can easily be subsumed by a...
7 years agoHow to Select a CMO in Biomanufacturing
Experts often regard biomanufacturing efficiency as the most important part of global bioprocessing. But efficiency can be almost impossible as companies juggle hundreds of priorities across dozens of areas in the pipeline. Best practice can easily be subsumed by a...
7 years ago
Clinical Operations: Biggest Challenges Facing the Industry in 2020
I’m often asked, by clients across the globe, what the main Clinical Operations challenges facing pharma and biotech companies really are. Where are they investing their resources? What takes up their time? Where are their efforts going to be focused...
7 years agoClinical Operations: Biggest Challenges Facing the Industry in 2020
I’m often asked, by clients across the globe, what the main Clinical Operations challenges facing pharma and biotech companies really are. Where are they investing their resources? What takes up their time? Where are their efforts going to be focused...
7 years ago
Weekly News Round-up – 14/2/20
The U.S. Institute for Clinical and Economic Review’s (ICER’s) methods could see legal challenges in the near future, a think tank has warned, due to discrimination against disabled individuals. In other news, Novartis’ rare lung cancer drug capmatinib will be...
7 years agoWeekly News Round-up – 14/2/20
The U.S. Institute for Clinical and Economic Review’s (ICER’s) methods could see legal challenges in the near future, a think tank has warned, due to discrimination against disabled individuals. In other news, Novartis’ rare lung cancer drug capmatinib will be...
7 years ago

The Changing Role of the Blockbuster Drug
There are few pharmaceutical companies not seeking the next big "blockbuster", a market drug earning revenue over $1 billion. These big-name products, which include Keytruda and Lipitor, are well-marketed and broadly-effective, often across several illnesses. For years scientists have worked...
7 years agoThe Changing Role of the Blockbuster Drug
There are few pharmaceutical companies not seeking the next big "blockbuster", a market drug earning revenue over $1 billion. These big-name products, which include Keytruda and Lipitor, are well-marketed and broadly-effective, often across several illnesses. For years scientists have worked...
7 years ago


Weekly News Round-up – 7/2/20
Two big pharma restructures this week,with both GSK and Merck making promises to spin off or divide their existing assets. GSK disappointed some investors with its £2.4 billion plan to separate its consumer health arm and save £700 million a...
7 years agoWeekly News Round-up – 7/2/20
Two big pharma restructures this week,with both GSK and Merck making promises to spin off or divide their existing assets. GSK disappointed some investors with its £2.4 billion plan to separate its consumer health arm and save £700 million a...
7 years ago

Trending Innovations in Cold Chain Processes
As is increasingly known in the pharmaceutical industry, the rise in both trial costs and drug failures has seen a corresponding increase in the need for tight regulations and stricter procedures, to ensure the few successes are not further compromised....
7 years agoTrending Innovations in Cold Chain Processes
As is increasingly known in the pharmaceutical industry, the rise in both trial costs and drug failures has seen a corresponding increase in the need for tight regulations and stricter procedures, to ensure the few successes are not further compromised....
7 years agoInterested?
Reserve your space

